Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Stock indices move when expectations and data shift; factors like economic data, earnings, and policy news all influence daily movements, shaping market direction.
27,810 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
SunPower's Q1 2026 results could set the tone for the year. This guide explains what to watch, which numbers matter, ...
Three practical lessons from SpaceX’s IPO can guide investors as Anthropic and OpenAI approach the market. Learn how ...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
Digimarc's Q1 2026 results shed light on its trajectory for the year. This analysis breaks down revenue, cash flow, a...
Emails released in SEC filings reveal a heated confrontation between UWM and Two Harbors as the CCM deal vote approac...
Goldman Sachs moves to remove DEI requirements for its board as conservative pressure grows. The move signals a wider...
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
A midlife couple faces a classic dilemma after selling a home: extinguish debt at 5% or invest the $175,000 cash pile...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
In February 2026, a disciplined $1,000 starter plan can still unlock meaningful exposure to AI-driven growth. This re...
Wedbush boosts its Micron price target to $500, arguing demand remains healthy after the Chinese New Year. The upgrad...